[go: up one dir, main page]

AU2001292773A1 - Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g - Google Patents

Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g

Info

Publication number
AU2001292773A1
AU2001292773A1 AU2001292773A AU9277301A AU2001292773A1 AU 2001292773 A1 AU2001292773 A1 AU 2001292773A1 AU 2001292773 A AU2001292773 A AU 2001292773A AU 9277301 A AU9277301 A AU 9277301A AU 2001292773 A1 AU2001292773 A1 AU 2001292773A1
Authority
AU
Australia
Prior art keywords
recombinantly
expression
sequence
preparation
soluble hla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292773A
Inventor
Joan S. Hunt
Pedro J. Morales
Margaret G. Petroff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas Medical Center
Original Assignee
University of Kansas Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas Medical Center filed Critical University of Kansas Medical Center
Publication of AU2001292773A1 publication Critical patent/AU2001292773A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001292773A 2000-09-15 2001-09-17 Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g Abandoned AU2001292773A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23276100P 2000-09-15 2000-09-15
US60232761 2000-09-15
PCT/US2001/029228 WO2002022784A2 (en) 2000-09-15 2001-09-17 Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g

Publications (1)

Publication Number Publication Date
AU2001292773A1 true AU2001292773A1 (en) 2002-03-26

Family

ID=22874459

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292773A Abandoned AU2001292773A1 (en) 2000-09-15 2001-09-17 Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g

Country Status (4)

Country Link
EP (1) EP1328290A2 (en)
AU (1) AU2001292773A1 (en)
CA (1) CA2425186A1 (en)
WO (1) WO2002022784A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011044A1 (en) * 2005-07-15 2007-01-25 Kyushu University, National University Corporation Pharmaceutical composition comprising disulfide-linked hla-g dimer and process for production of disulfide-linked hla-g dimer
EP2184297A1 (en) * 2008-11-07 2010-05-12 Hla-G Technologies HLA-G polypeptides and pharmaceutical uses thereof
EP2264067A1 (en) * 2009-06-18 2010-12-22 Hla-G Technologies HLA-G alpha 1 multimers and pharmaceutical uses thereof
EP2443147A1 (en) * 2009-06-18 2012-04-25 Hla-G Technologies Hla-g alpha 1 multimers and pharmaceutical uses thereof
EP2730588A1 (en) 2012-11-12 2014-05-14 Intelectys Antibodies and fragments thereof raised against the alpha-3 domain of HLA-G protein, methods and means for their preparation, and uses thereof
TW201829463A (en) 2016-11-18 2018-08-16 瑞士商赫孚孟拉羅股份公司 anti-HLA-G antibody and use thereof
AR114789A1 (en) 2018-04-18 2020-10-14 Hoffmann La Roche ANTI-HLA-G ANTIBODIES AND THE USE OF THEM
CN113166243B (en) 2018-09-27 2023-03-24 提泽纳治疗公司 anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies, and methods of using anti-HLA-G antibodies
CA3204702A1 (en) 2020-12-17 2022-06-23 F. Hoffmann-La Roche Ag Anti-hla-g antibodies and use thereof

Also Published As

Publication number Publication date
EP1328290A2 (en) 2003-07-23
WO2002022784A2 (en) 2002-03-21
WO2002022784A3 (en) 2002-06-06
CA2425186A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU2002217226A1 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
HUP0300527A3 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001240753A1 (en) Lipid nanocapsules, preparation method and use as medicine
AU7429100A (en) Chondrocyte compositions, preparation and use thereof
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001248279A1 (en) New compounds, their preparation and use
AU4549499A (en) Polyurea-based adhesives, articles therefrom, and methods of their preparation and use
AU2002359126A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2001286701A1 (en) Hyaluronan-based antiadhesion compositions, their preparation and use
AU2002359123A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002241508A1 (en) Membrane derived caspase-3, compositions comprising the same and methods of use therefor
AU5886500A (en) Indolyl-benzimidazole antibacterials, and methods of use thereof
WO2002036145A8 (en) Kahalalide f formulation
AU2002243392A1 (en) Immunogenic proteoliposomes, and uses thereof
AU2001292773A1 (en) Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU5368699A (en) Derivatives of triptolide, and preparation and uses thereof
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001234616A1 (en) Vaccine composition, process and methods
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2002246585A1 (en) Plant promoters, and methods of use
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof